Next Article in Journal
Risk of Hearing Loss in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors
Previous Article in Journal
Identification of 3-[(4-Acetylphenyl)(4-Phenylthiazol-2-Yl)Amino]Propanoic Acid Derivatives as Promising Scaffolds for the Development of Novel Anticancer Candidates Targeting SIRT2 and EGFR
Previous Article in Special Issue
Small Molecules in the Treatment of Acute Severe Ulcerative Colitis: A Review of Current Evidence
 
 
Article

Article Versions Notes

Pharmaceuticals 2025, 18(5), 734; https://doi.org/10.3390/ph18050734
Action Date Notes Link
article html file updated 15 September 2025 06:50 CEST Update https://www.mdpi.com/1424-8247/18/5/734/html
article html file updated 28 August 2025 07:46 CEST Update -
article html file updated 25 June 2025 04:43 CEST Update -
article html file updated 16 May 2025 13:19 CEST Original file -
article supplementary file uploaded. 16 May 2025 13:15 CEST - https://www.mdpi.com/1424-8247/18/5/734#supplementary
article pdf uploaded. 16 May 2025 13:15 CEST Version of Record https://www.mdpi.com/1424-8247/18/5/734/pdf
article xml uploaded. 16 May 2025 13:15 CEST Update https://www.mdpi.com/1424-8247/18/5/734/xml
article xml file uploaded 16 May 2025 13:15 CEST Original file -
Back to TopTop